Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population

BACKGROUND: Information on overall survival (OS) and adverse events (AEs) in patients with chronic lymphocytic leukemia (CLL) is mostly available from clinical trials. We therefore conducted a population‐based retrospective cohort study to assess OS, incidence of AEs, and economic burden in real‐wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Ravi K., Nagar, Saurabh P., Kabadi, Shaum M., Le, Hannah, Davis, Keith L., Kaye, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026937/
https://www.ncbi.nlm.nih.gov/pubmed/33734606
http://dx.doi.org/10.1002/cam4.3855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026937/
https://www.ncbi.nlm.nih.gov/pubmed/33734606
http://dx.doi.org/10.1002/cam4.3855

Ejemplares similares